Rare diseases
Investigational molecules
Locations
Total-Body PET with [18F]Flutemetamol in Patients with Post-COVID Syndrome (Long COVID)
The NetherlandsComparison of Three PET Tau Tracers ([18F]RO948, [18F]PI2620, and [18F]MK-6240) in People with Cognitive Impairment
SpainStudy on the Accuracy of Tau PET ([18F]RO6958948) and Vizamyl (Flutemetamol 18F) in Diagnosing Mild Cognitive Symptoms and Risk of Alzheimer's Disease
SwedenStudy on Brain Changes in Alzheimer's Disease Using Flutemetamol (18F) and Fludeoxyglucose (18F) in ALFA Project Participants
SpainStudy on Flutemetamol (18F) for Detecting Amyloid Pathology in Cognitively Normal Elderly at Risk for Alzheimer's Disease
The NetherlandsStudy on Gadobutrol for Patients with Idiopathic Normal Pressure Hydrocephalus to Understand Cerebrospinal Fluid Movement Using MRI
SwedenStudy on the Benefits of Amyloid PET Imaging with Florbetaben (18F) and Flutemetamol (18F) for Patients with Various Types of Dementia
GermanyStudy on the Effects of Sabirnetug for Patients with Early Alzheimer's Disease
FranceStudy on BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia
BelgiumStudy of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer's Disease
DenmarkA study testing trontinemab compared to placebo in patients with early Alzheimer's disease including mild cognitive impairment and mild dementia
DenmarkStudy on the Use of Flutemetamol (18F) for Diagnosing Cardiac Amyloidosis in Patients
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
